Document is current
Any future updates will be listed below
-
Authors
Zhang, Zhiwei https://orcid.org/0000-0002-6478-8277
Le, Giang N. T. https://orcid.org/0000-0002-0141-8447
Ge, Yang https://orcid.org/0000-0003-3139-9053
Tang, Xiaowen https://orcid.org/0000-0001-6285-6777
Chen, Xin
Ejim, Linda
Bordeleau, Emily https://orcid.org/0009-0008-9725-6614
Wright, Gerard D.
Burns, Darcy C.
Tran, Susannah
Axerio-Cilies, Peter https://orcid.org/0000-0003-4496-1172
Wang, Yu Tian https://orcid.org/0000-0001-8592-0698
Dong, Mingxin https://orcid.org/0000-0001-8623-0146
Woolley, G. Andrew https://orcid.org/0000-0002-3446-2639
- License Information
-
More Information
Article History
Received: 2 February 2022
Accepted: 12 May 2023
First Online: 12 June 2023
Competing interests
: No financial interest or any direct conflict of interest exists. Y.T.W. and P.A.-C. declare an internationalized patent related to this class of NPAM compounds (<i>N</i>-methyl-<scp>d</scp>-aspartate receptor (NMDAR) allosteric modulators and methods for their use, WO 2018/107853 A2).
